Collegium Pharmaceutical (COLL) Finished Goods (2016 - 2025)

Collegium Pharmaceutical's Finished Goods history runs 10 years deep, the most recent figure standing at $20.2 million for Q3 2025.

• In Q3 2025, Finished Goods rose 23.13% year-over-year to $20.2 million; the TTM figure through Sep 2025 stood at $20.2 million (up 23.13% YoY), while the FY2024 annual figure was $17.8 million, up 17.12% from the prior year.
• Finished Goods was $20.2 million for Q3 2025 at Collegium Pharmaceutical, roughly flat from $20.2 million in the prior quarter.
• In the past five years, Finished Goods ranged from a high of $36.9 million in Q1 2022 to a low of $9.5 million in Q2 2021.
• Historically, Finished Goods has averaged $16.5 million across 5 years, with a median of $15.2 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Finished Goods soared 280.78% in 2022, then sank 62.81% in 2023.
• A 5-year view of Finished Goods shows it stood at $12.7 million in 2021, then rose by 27.77% to $16.2 million in 2022, then decreased by 6.29% to $15.2 million in 2023, then grew by 17.12% to $17.8 million in 2024, then increased by 13.64% to $20.2 million in 2025.
• The last three Finished Goods figures came in at $20.2 million (Q3 2025), $20.2 million (Q2 2025), and $18.5 million (Q1 2025), per Business Quant data.